These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 2553254
21. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines. Robson CN, Hoban PR, Harris AL, Hickson ID. Cancer Res; 1987 Mar 15; 47(6):1560-5. PubMed ID: 2434220 [Abstract] [Full Text] [Related]
22. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells. Markovits J, Pommier Y, Kerrigan D, Covey JM, Tilchen EJ, Kohn KW. Cancer Res; 1987 Apr 15; 47(8):2050-5. PubMed ID: 3030540 [Abstract] [Full Text] [Related]
23. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II. Baloch Z, Cohen S, Coffman FD. J Immunol; 1990 Nov 01; 145(9):2908-13. PubMed ID: 2170526 [Abstract] [Full Text] [Related]
25. DNA repair enzyme, O6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors. Kuo CC, Liu JF, Chang JY. J Pharmacol Exp Ther; 2006 Feb 01; 316(2):946-54. PubMed ID: 16258022 [Abstract] [Full Text] [Related]
26. A comparison of the effects of aphidicolin and other inhibitors on topoisomerase II-directed cytotoxic drugs. Haldane A, Finlay GJ, Baguley BC. Oncol Res; 1993 Feb 01; 5(3):133-8. PubMed ID: 8260750 [Abstract] [Full Text] [Related]
28. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Covey JM, Jaxel C, Kohn KW, Pommier Y. Cancer Res; 1989 Sep 15; 49(18):5016-22. PubMed ID: 2548707 [Abstract] [Full Text] [Related]
29. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Caldecott K, Banks G, Jeggo P. Cancer Res; 1990 Sep 15; 50(18):5778-83. PubMed ID: 2168280 [Abstract] [Full Text] [Related]
30. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors. Dereuddre S, Delaporte C, Jacquemin-Sablon A. Cancer Res; 1997 Oct 01; 57(19):4301-8. PubMed ID: 9331091 [Abstract] [Full Text] [Related]
31. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity. Poot M, Hiller KH, Heimpel S, Hoehn H. Exp Cell Res; 1995 May 01; 218(1):326-30. PubMed ID: 7537696 [Abstract] [Full Text] [Related]
32. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs. Epstein RJ, Smith PJ. Cancer Res; 1988 Jan 15; 48(2):297-303. PubMed ID: 2825970 [Abstract] [Full Text] [Related]
34. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors. Khélifa T, René B, Le Mée S, Lambert B, Saucier JM, Markovits J, Jacquemin-Sablon H, Jacquemin-Sablon A. Cancer Res; 1999 Oct 01; 59(19):4927-36. PubMed ID: 10519406 [Abstract] [Full Text] [Related]
40. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides. Davies SM, Davies SL, Harris AL, Hickson ID. Cancer Res; 1989 Aug 15; 49(16):4526-30. PubMed ID: 2545343 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]